Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""bipolar disorder"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 5393
Tytuł:
Optical determination of lithium therapeutic levels in micro-volumes of interstitial fluid.
Autorzy:
Sheikh M; Research Centre for Biomedical Engineering, City University of London, London, UK.
Qassem M; Research Centre for Biomedical Engineering, City University of London, London, UK.
Kyriacou PA; Research Centre for Biomedical Engineering, City University of London, London, UK.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2023 Mar; Vol. 25 (2), pp. 136-147. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/drug therapy
Humans ; Animals ; Swine ; Extracellular Fluid ; Reproducibility of Results ; Mood Disorders/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The paradox of vanishing lithium.
Autorzy:
Pahwa M; Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Elsayed OH; Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
El-Mallakh RS; Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2023 Mar; Vol. 25 (2), pp. 97-98.
Typ publikacji:
Editorial
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/drug therapy
Humans ; Antimanic Agents/therapeutic use ; Valproic Acid/therapeutic use ; Lithium Compounds/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Information theory characteristics improve the prediction of lithium response in bipolar disorder patients using a support vector machine classifier.
Autorzy:
Tripathi U; Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Mizrahi L; Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Alda M; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Falkovich G; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.
Stern S; Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2023 Mar; Vol. 25 (2), pp. 110-127. Date of Electronic Publication: 2022 Dec 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/diagnosis
Humans ; Support Vector Machine ; Lithium Compounds/therapeutic use ; Information Theory
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lithium first: Not merely first line.
Autorzy:
Malhi GS; Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T, Royal North Shore Hospital, Northern Sydney Local Health District, Sydney, New South Wales, Australia.; Visiting Professor, Department of Psychiatry, University of Oxford, Oxford, UK.; Oxford Uehiro Centre for Practical Ethics, Faculty of Philosophy, University of Oxford, Oxford, UK.
Bauer M; Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2023 Feb; Vol. 25 (1), pp. 7-8.
Typ publikacji:
Editorial
MeSH Terms:
Lithium*
Bipolar Disorder*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk factors for early recurrence after discontinuing lithium in bipolar disorder.
Autorzy:
Baldessarini RJ; International Consortium for Mood & Psychotic Disorder Research, McLean Hospital, Belmont, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Pinna M; Lucio Bini Mood Disorder Centers, Cagliari & Rome, Rome, Italy.
Contu M; Lucio Bini Mood Disorder Centers, Cagliari & Rome, Rome, Italy.
Vázquez GH; International Consortium for Mood & Psychotic Disorder Research, McLean Hospital, Belmont, Massachusetts, USA.; Department of Psychiatry, Queen's University School of Medicine, Kingston, Ontario, Canada.
Tondo L; International Consortium for Mood & Psychotic Disorder Research, McLean Hospital, Belmont, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Lucio Bini Mood Disorder Centers, Cagliari & Rome, Rome, Italy.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2022 Nov; Vol. 24 (7), pp. 720-725. Date of Electronic Publication: 2022 Apr 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/drug therapy
Bipolar Disorder*/epidemiology
Humans ; Risk Factors ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of Lithium Treatment With Reduced Left Ventricular Concentricity in Patients With Bipolar Disorder.
Autorzy:
Chen PH; Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan.; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Hsiao CY; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chiang SJ; Division of Cardiology, Department of Internal Medicine, Taipei City Hospital Yangming Branch, Taipei, Taiwan.; School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Tsai SY; Department of Psychiatry, Taipei Medical University Hospital, Taipei, Taiwan.; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Pokaż więcej
Źródło:
Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2023 Jan; Vol. 77 (1), pp. 59-61. Date of Electronic Publication: 2022 Nov 13.
Typ publikacji:
Letter
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/drug therapy
Humans ; Antimanic Agents/therapeutic use ; Patients ; Lithium Compounds/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lithium replacement dose recommendations using Monte Carlo simulations.
Autorzy:
Methaneethorn J; Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.; Center of Excellence for Environmental Health and Toxicology, Naresuan University, Phitsanulok, Thailand.
Mannie Z; Academic Department of Psychiatry, Faculty of Medicine and Health, Kolling Institute, Northern Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T Service, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.; Royal North Shore Hospital, NSW Health, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.
Bell E; Academic Department of Psychiatry, Faculty of Medicine and Health, Kolling Institute, Northern Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T Service, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.
Malhi GS; Academic Department of Psychiatry, Faculty of Medicine and Health, Kolling Institute, Northern Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; CADE Clinic and Mood-T Service, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.; Department of Psychiatry, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2022 Nov; Vol. 24 (7), pp. 739-748. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lithium*
Bipolar Disorder*
Humans ; Monte Carlo Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of immediate and sustained release formulations of lithium salts.
Autorzy:
Pompili M; Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Italy, Rome, Italy.; International Consortium for Mood and Psychotic Disorder Research, Mailman Research Center, McLean Hospital, Belmont, MA, USA.
Magistri C; Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Mellini C; Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Sarli G; Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy.
Baldessarini RJ; International Consortium for Mood and Psychotic Disorder Research, Mailman Research Center, McLean Hospital, Belmont, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
International review of psychiatry (Abingdon, England) [Int Rev Psychiatry] 2022 Nov-Dec; Vol. 34 (7-8), pp. 753-759. Date of Electronic Publication: 2022 Sep 21.
Typ publikacji:
Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lithium*/therapeutic use
Bipolar Disorder*/drug therapy
Humans ; Salts/therapeutic use ; Delayed-Action Preparations/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients, poorly tolerant to lithium immediate-release treatment: A randomized clinical trial.
Autorzy:
Pelacchi F; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Dell'Osso L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Bondi E; Psychiatric Service Diagnosis and Care, Papa Giovanni XXIII Hospital, Bergamo, Italy.
Amore M; Institute of Rehabilitation and Care for Scientific Character San Martino Polyclinic Hospital, University Psychiatric Clinic, Genova, Italy.
Fagiolini A; Psychiatry, University-Hospital of Siena, Siena, Italy.
Iazzetta P; Functional Unit Mental Health Adults, San Giovanni di Dio Hospital, Orbetello-Grosseto, Italy.
Pierucci D; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Gorini M; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Quarchioni E; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Comandini A; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Salvatori E; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Cattaneo A; Global Medical Department, Angelini Pharma S.p.A., Rome, Italy.
Pompili M; Complex Operational Unit Psychiatry, Sant'Andrea University-Hospital, University of Rome La Sapienza, Rome, Italy.
Pokaż więcej
Corporate Authors:
SALT Study Group
Źródło:
Brain and behavior [Brain Behav] 2022 Mar; Vol. 12 (3), pp. e2485. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/diagnosis
Bipolar Disorder*/drug therapy
Lithium*/adverse effects
Double-Blind Method ; Humans ; Psychiatric Status Rating Scales ; Treatment Outcome ; Tremor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dynamic insulin-stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorder.
Autorzy:
Tye SJ; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.; Queensland Brain Institute, The University of Queensland, St Lucia, Qld, Australia.; Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
Borreggine K; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Price JB; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.; Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
Sutor SL; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Cuéllar-Barboza AB; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.; Department of Psychiatry, Autonomous University of Nuevo Leon School of Medicine, Monterrey, Mexico.
McElroy SL; Lindner Center of HOPE, Mason, OH, USA.; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Biernacka JM; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Frye MA; Mayo Clinic Depression Center, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2022 Feb; Vol. 24 (1), pp. 39-47. Date of Electronic Publication: 2021 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/pharmacology
Lithium*/therapeutic use
Glycogen Synthase Kinase 3 ; Glycogen Synthase Kinase 3 beta ; Humans ; Insulin ; Leukocytes, Mononuclear/metabolism ; TOR Serine-Threonine Kinases/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder.
Autorzy:
Sheikh M; Research Centre for Biomedical Engineering, City University of London, London EC1V 0HB, UK.
Qassem M; Research Centre for Biomedical Engineering, City University of London, London EC1V 0HB, UK.
Triantis IF; Research Centre for Biomedical Engineering, City University of London, London EC1V 0HB, UK.
Kyriacou PA; Research Centre for Biomedical Engineering, City University of London, London EC1V 0HB, UK.
Pokaż więcej
Źródło:
Sensors (Basel, Switzerland) [Sensors (Basel)] 2022 Jan 19; Vol. 22 (3). Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Humans ; Ion-Selective Electrodes ; Photometry ; Spectrum Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double-blind, randomized, placebo-controlled, clinical trial.
Autorzy:
Badrfam R; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Department of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mostafavi SA; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Khaleghi A; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Akhondzadeh S; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zandifar A; Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Department of Psychiatry, Imam Hossein Hospital, Alborz University of Medical Sciences, Karaj, Iran.
Farid M; Non communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Mohammadian Khonsari N; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran.
Mohammadi MR; Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2021 Nov; Vol. 11 (11), pp. e2394. Date of Electronic Publication: 2021 Oct 17.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Double-Blind Method ; Drug Therapy, Combination ; Humans ; Mania ; Psychiatric Status Rating Scales ; Treatment Outcome ; Vitamin B 6/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis.
Autorzy:
Hsu CW; Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.; Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.
Carvalho AF; IMPACT (Innovation in Mental and Physical Health and Clinical Treatment) Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia.
Tsai SY; Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Psychiatry and Psychiatric Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
Wang LJ; Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.; Department of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Tseng PT; Prospect Clinic for Otorhinolaryngology & Neurology, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.; Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan.
Lin PY; Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.; Institute for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Tu YK; Institute of Epidemiology & Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan.
Vieta E; Bipolar and Depressive Disorders Unit, Hospital Clinic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain.
Solmi M; Neurosciences Department, University of Padua, Padua, Italy.; Neuroscience Centre, University of Padua, Padua, Italy.
Hung CF; Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Kao HY; Department of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.
Pokaż więcej
Źródło:
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2021 Oct; Vol. 144 (4), pp. 368-378. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji:
Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/drug therapy
Bipolar Disorder*/epidemiology
Lithium*/therapeutic use
Antimanic Agents/therapeutic use ; Cohort Studies ; Humans ; Recurrence ; Retrospective Studies ; Risk
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders.
Autorzy:
Le Clerc S; Laboratoire Génomique, Bio-Informatique et Chimie Moléculaire (EA7528), Conservatoire National des Arts et Métiers, HESAM Université, 292, rue Saint Martin, 75003, Paris, France.
Lombardi L; AP-HP, Hôpital Henri Mondor, Département Médico-Universitaire de Psychiatrie et D'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision (FHU ADAPT), 94010, Créteil, France.; INSERM U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, 94010, Créteil, France.; Fondation FondaMental, Créteil, France.
Baune BT; Department of Psychiatry, University of Münster, Münster, Germany.; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia.; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne Parkville, Parkville, VIC, Australia.
Amare AT; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.; South Australian Academic Health Science and Translation Centre, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Schubert KO; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.; Mental Health Services, Northern Adelaide Local Health Network, Adelaide, SA, Australia.
Hou L; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
Clark SR; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Papiol S; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Nußbaumstr. 7, 80336, Munich, Germany.; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany.
Cearns M; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Heilbronner U; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Nußbaumstr. 7, 80336, Munich, Germany.
Degenhardt F; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Tekola-Ayele F; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Hsu YH; HSL Institute for Aging Research, Harvard Medical School, Boston, MA, USA.; Program for Quantitative Genomics, Harvard School of Public Health, Boston, MA, USA.
Shekhtman T; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Adli M; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
Akula N; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
Akiyama K; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Ardau R; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
Arias B; Unitat de Zoologia I Antropologia Biològica (Dpt. Biologia Evolutiva, Ecologia I Ciències Ambientals), Facultat de Biologia and Institut de Biomedicina (IBUB), University of Barcelona, CIBERSAM, Barcelona, Spain.
Aubry JM; Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, Geneva, Switzerland.
Backlund L; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Bhattacharjee AK; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Bellivier F; INSERM UMR-S 1144, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Université Paris Diderot, Paris, France.
Benabarre A; Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Bengesser S; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.
Biernacka JM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Birner A; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.
Brichant-Petitjean C; INSERM UMR-S 1144, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Université Paris Diderot, Paris, France.
Cervantes P; The Neuromodulation Unit, McGill University Health Centre, Montreal, QC, Canada.
Chen HC; Department of Psychiatry & Center of Sleep Disorders, National Taiwan University Hospital, Taipei, Taiwan.
Chillotti C; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
Cichon S; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Cruceanu C; Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Czerski PM; Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
Dalkner N; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.
Dayer A; Department of Psychiatry, Mood Disorders Unit, HUG - Geneva University Hospitals, Geneva, Switzerland.
Del Zompo M; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
DePaulo JR; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Étain B; INSERM UMR-S 1144, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Université Paris Diderot, Paris, France.
Jamain S; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, Créteil, France.
Falkai P; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany.
Forstner AJ; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.; Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.; Centre for Human Genetics, University of Marburg, Marburg, Germany.
Frisen L; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Fullerton JM; Neuroscience Research Australia, Sydney, NSW, Australia.; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
Gard S; Service de Psychiatrie, Hôpital Charles Perrens, Bordeaux, France.
Garnham JS; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Goes FS; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Grigoroiu-Serbanescu M; Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.
Grof P; Mood Disorders Center of Ottawa, Ottawa, ON, Canada.
Hashimoto R; Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Hauser J; Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
Herms S; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Hoffmann P; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Jiménez E; Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Kahn JP; Service de Psychiatrie Et Psychologie Clinique, Centre Psychothérapique de Nancy - Université de Lorraine, Nancy, France.
Kassem L; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
Kuo PH; Department of Public Health & Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Kato T; Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kelsoe JR; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Kittel-Schneider S; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
Ferensztajn-Rochowiak E; Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
König B; Department of Psychiatry and Psychotherapeutic Medicine, Landesklinikum Neunkirchen, Neunkirchen, Austria.
Kusumi I; Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Laje G; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
Landén M; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the Gothenburg University, Gothenburg, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Lavebratt C; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Leckband SG; Office of Mental Health, VA San Diego Healthcare System, San Diego, CA, USA.
Tortorella A; Department of Psychiatry, University of Perugia, Perugia, Italy.
Manchia M; Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
Martinsson L; Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
McCarthy MJ; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.; Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.
McElroy SL; Department of Psychiatry, Lindner Center of Hope/University of Cincinnati, Mason, OH, USA.
Colom F; Mental Health Research Group, IMIM-Hospital del Mar, Barcelona, Catalonia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Millischer V; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Mitjans M; Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain.; Centro de Investigación Biomédica en Salud Mental (CIBERSAM), Madrid, Spain.
Mondimore FM; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Monteleone P; Neurosciences Section, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy.; Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Nievergelt CM; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Nöthen MM; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Novák T; National Institute of Mental Health, Klecany, Czech Republic.
O'Donovan C; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Ozaki N; Department of Psychiatry & Department of Child and Adolescent Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ösby U; Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Pfennig A; Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Potash JB; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Reif A; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
Reininghaus E; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for Bipolar Affective Disorder, Medical University of Graz, Graz, Austria.
Rouleau GA; Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Rybakowski JK; Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Schalling M; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Schofield PR; Neuroscience Research Australia, Sydney, NSW, Australia.; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
Schweizer BW; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Severino G; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Shilling PD; Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Shimoda K; Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Simhandl C; Bipolar Center Wiener Neustadt, Medical Faculty, Sigmund Freud University, Vienna, Austria.
Slaney CM; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Pisanu C; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Squassina A; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Stamm T; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
Stopkova P; National Institute of Mental Health, Klecany, Czech Republic.
Maj M; Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Turecki G; Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Vieta E; Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Veeh J; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
Witt SH; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Wright A; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Zandi PP; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Mitchell PB; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Bauer M; Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Alda M; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Rietschel M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
McMahon FJ; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
Schulze TG; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Nußbaumstr. 7, 80336, Munich, Germany.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany.
Spadoni JL; Laboratoire Génomique, Bio-Informatique et Chimie Moléculaire (EA7528), Conservatoire National des Arts et Métiers, HESAM Université, 292, rue Saint Martin, 75003, Paris, France.
Boukouaci W; INSERM U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, 94010, Créteil, France.; Fondation FondaMental, Créteil, France.
Richard JR; INSERM U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, 94010, Créteil, France.
Le Corvoisier P; Centre Investigation Clinique, CIC Henri Mondor, Université Paris Est Créteil, 94010, Créteil, France.
Barrau C; Plateforme de Ressources Biologiques, HU Henri Mondor, 94010, Créteil, France.
Zagury JF; Laboratoire Génomique, Bio-Informatique et Chimie Moléculaire (EA7528), Conservatoire National des Arts et Métiers, HESAM Université, 292, rue Saint Martin, 75003, Paris, France.
Leboyer M; AP-HP, Hôpital Henri Mondor, Département Médico-Universitaire de Psychiatrie et D'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision (FHU ADAPT), 94010, Créteil, France.; INSERM U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, 94010, Créteil, France.; Fondation FondaMental, Créteil, France.
Tamouza R; AP-HP, Hôpital Henri Mondor, Département Médico-Universitaire de Psychiatrie et D'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision (FHU ADAPT), 94010, Créteil, France. .; INSERM U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, 94010, Créteil, France. .; Fondation FondaMental, Créteil, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Sep 08; Vol. 11 (1), pp. 17823. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Predisposition to Disease*
Bipolar Disorder/*genetics
HLA-DQ beta-Chains/*genetics
HLA-DRB1 Chains/*genetics
Lithium/*therapeutic use
Adult ; Alleles ; Bipolar Disorder/drug therapy ; Female ; Gene Frequency ; Genetic Variation ; Genotype ; Haplotypes ; Humans ; Male ; Middle Aged ; Pharmacogenetics ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Lithium orotate: A superior option for lithium therapy?
Autorzy:
Pacholko AG; Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Bekar LK; Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Pokaż więcej
Źródło:
Brain and behavior [Brain Behav] 2021 Aug; Vol. 11 (8), pp. e2262. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Antimanic Agents/therapeutic use ; Humans ; Lithium Compounds/adverse effects ; Organometallic Compounds
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ultra-long-term lithium therapy: all-important matters and a case of successful 50-year lithium treatment.
Autorzy:
Ferensztajn-Rochowiak E; Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Chłopocka-Woźniak M; Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Rybakowski JK; Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Pokaż więcej
Źródło:
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) [Braz J Psychiatry] 2021 Jul-Aug; Vol. 43 (4), pp. 407-413.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bipolar Disorder*/chemically induced
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Anticonvulsants/therapeutic use ; Antimanic Agents/adverse effects ; Female ; Humans ; Lithium Compounds/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Quantification of brain proton longitudinal relaxation (T 1 ) in lithium-treated and lithium-naïve patients with bipolar disorder in comparison to healthy controls.
Autorzy:
Necus J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Interdisciplinary Computing and Complex BioSystems (ICOS), School of Computing Science, Newcastle University, Newcastle upon Tyne, UK.
Smith FE; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK.
Thelwall PE; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK.
Flowers CJ; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Sinha N; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Interdisciplinary Computing and Complex BioSystems (ICOS), School of Computing Science, Newcastle University, Newcastle upon Tyne, UK.
Taylor PN; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Interdisciplinary Computing and Complex BioSystems (ICOS), School of Computing Science, Newcastle University, Newcastle upon Tyne, UK.; Institute of Neurology, University College London, London, UK.
Blamire AM; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, UK.
Wang Y; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Interdisciplinary Computing and Complex BioSystems (ICOS), School of Computing Science, Newcastle University, Newcastle upon Tyne, UK.; Institute of Neurology, University College London, London, UK.
Cousins DA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Northumberland Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2021 Feb; Vol. 23 (1), pp. 41-48. Date of Electronic Publication: 2019 Dec 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/diagnostic imaging
Bipolar Disorder*/drug therapy
Lithium*
Brain/diagnostic imaging ; Humans ; Lithium Compounds ; Magnetic Resonance Imaging ; Protons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel mechanism of action for the mood stabilizer lithium.
Autorzy:
Abu-Hijleh FA; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Prashar S; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Joshi H; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Sharma R; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Frey BN; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.; Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare, Hamilton, ON, Canada.
Mishra RK; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2021 Feb; Vol. 23 (1), pp. 76-83. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/pharmacology
Animals ; Endoplasmic Reticulum ; Endoplasmic Reticulum Chaperone BiP ; Male ; Mice ; Nerve Growth Factors ; Rats ; Rats, Sprague-Dawley ; Transcription Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum lithium test requesting across three UK regions: an evaluation of adherence to monitoring guidelines.
Autorzy:
Parfitt C; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.
Duff CJ; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.; School of Medicine, Keele University, Keele, Stoke-on-Trent, Staffordshire, UK.
Scargill J; Department of Clinical Biochemistry, The Royal Oldham Hospital, The Northern Care Alliance NHS Group, Oldham, UK.
Green L; Department of Clinical Biochemistry, The Royal Oldham Hospital, The Northern Care Alliance NHS Group, Oldham, UK.; St. Helens & Knowsley Teaching Hospitals NHS Trust, Whiston Hospital, Prescot, UK.
Holland D; The Benchmarking Partnership, Alsager, Cheshire, UK.
Heald AH; Salford Royal Hospital NHS Foundation Trust, The Northern Care Alliance NHS Group, Salford, UK.; The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Fryer AA; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK. .; School of Medicine, Keele University, Keele, Stoke-on-Trent, Staffordshire, UK. .; Professor of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Keele University, Stoke-on-Trent, Staffordshire, ST5 5BG, UK. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2021 Jan 12; Vol. 21 (1), pp. 32. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Bipolar Disorder*/diagnosis
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Adult ; Aged ; Humans ; Lithium Compounds ; Secondary Care ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The rebirth of lithium as the archetypal mood stabilizer.
Autorzy:
Carvalho AF; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Centre for Addiction and Mental Health (CAMH, Toronto, ON, Canada.; Barwon Health, School of Medicine, Deakin University, Institute for Mental and Physical Health and Clinical Translation, Geelong, Australia.
Solmi M; Department of Neurosciences, University of Padova, Padova, Italy.
Husain MI; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Centre for Addiction and Mental Health (CAMH, Toronto, ON, Canada.
Berk M; Barwon Health, School of Medicine, Deakin University, Institute for Mental and Physical Health and Clinical Translation, Geelong, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Department of Psychiatry, Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
Vieta E; Barcelona Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
Pokaż więcej
Źródło:
Bipolar disorders [Bipolar Disord] 2021 Mar; Vol. 23 (2), pp. 211-212. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bipolar Disorder*/drug therapy
Lithium*/therapeutic use
Antimanic Agents/therapeutic use ; Humans ; Psychotropic Drugs/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 5393

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies